β Amyloid 1-42 Antibody [H15J22]

Catalog No.: F3375

Application: Reactivity: Mouse, Rat, Human

Immunohistochemical analysis of formalin fixed paraffin embedded human brain tissue with F3375 at 1:1000 dilution.

サイズ	価格(税別)	在庫状況
20uL	JPY 24800	国内在庫なし(納期7~10日)
100uL	JPY 60800	国内在庫なし(納期7~10日)
100uL*2	JPY 91200	お問い合わせ

代表番号: 045-509-1970\|電子メール：sales@selleck.co.jp よく尋ねられる質問

使用情報

Dilution
IHC1:1000

Application
IHC

Source
Rabbit Monoclonal Antibody

Reactivity
Mouse, Rat, Human

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

ポジティブコントロール	Human alzheimer brain
ネガティブコントロール

プロトコール

IHC
Experimental Protocol： Deparaffinization/Rehydration 1. Deparaffinize/hydrate sections: 2. Incubate sections in three washes of xylene for 5 min each. 3. Incubate sections in two washes of 100% ethanol for 10 min each. 4. Incubate sections in two washes of 95% ethanol for 10 min each. 5. Wash sections two times in dH2O for 5 min each. 6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min. Staining 1. Wash sections in dH2O three times for 5 min each. 2. Incubate sections in 3% hydrogen peroxide for 10 min. 3. Wash sections in dH2O two times for 5 min each. 4. Wash sections in wash buffer for 5 min. 5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature. 6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C. 7. Remove antibody solution and wash sections with wash buffer three times for 5 min each. 8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature. 9. Wash sections three times with wash buffer for 5 min each. 10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use. 11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity. 12. Immerse slides in dH2O. 13. If desired, counterstain sections with hematoxylin. 14. Wash sections in dH2O two times for 5 min each. 15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each. 16. Mount sections with coverslips and mounting medium.

IHC

Experimental Protocol：

Deparaffinization/Rehydration

1. Deparaffinize/hydrate sections:

2. Incubate sections in three washes of xylene for 5 min each.

3. Incubate sections in two washes of 100% ethanol for 10 min each.

4. Incubate sections in two washes of 95% ethanol for 10 min each.

5. Wash sections two times in dH2O for 5 min each.

6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.

Staining

1. Wash sections in dH2O three times for 5 min each.

2. Incubate sections in 3% hydrogen peroxide for 10 min.

3. Wash sections in dH2O two times for 5 min each.

4. Wash sections in wash buffer for 5 min.

5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.

6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.

7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.

8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.

9. Wash sections three times with wash buffer for 5 min each.

10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.

11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.

12. Immerse slides in dH2O.

13. If desired, counterstain sections with hematoxylin.

14. Wash sections in dH2O two times for 5 min each.

15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.

16. Mount sections with coverslips and mounting medium.

Datasheet & SDS

生物学的記述

Specificity
β Amyloid 1-42 Antibody [H15J22] detects endogenous levels of total β Amyloid 1-42 protein.

タンパク質の局在
アミロイド、細胞膜、細胞突起、被覆小窩、細胞質、細胞質小胞、小胞体、エンドソーム、ゴルジ装置

Uniprot ID
P05067

Clone
H15J22

Synonym(s)
A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II

Background
Amyloid β 1-42 (Aβ42) is a 42–amino acid peptide generated from the amyloid precursor protein (APP) through sequential cleavage by β-secretase and γ-secretase in neurons. Structurally, Aβ42 is highly hydrophobic at its C-terminus, promoting a conformational shift from α-helix to β-sheet that facilitates aggregation into soluble oligomers, protofibrils, and insoluble amyloid fibrils. Aβ42 is expressed primarily in the brain, especially in the neocortex, and is more aggregation-prone and neurotoxic than the shorter Aβ40 form. Functionally, pathological accumulation of Aβ42—particularly as soluble oligomers—is strongly implicated in Alzheimer’s disease pathogenesis by disrupting synaptic signaling, impairing memory, and contributing to plaque formation.

Background

Amyloid β 1-42 (Aβ42) is a 42–amino acid peptide generated from the amyloid precursor protein (APP) through sequential cleavage by β-secretase and γ-secretase in neurons. Structurally, Aβ42 is highly hydrophobic at its C-terminus, promoting a conformational shift from α-helix to β-sheet that facilitates aggregation into soluble oligomers, protofibrils, and insoluble amyloid fibrils. Aβ42 is expressed primarily in the brain, especially in the neocortex, and is more aggregation-prone and neurotoxic than the shorter Aβ40 form. Functionally, pathological accumulation of Aβ42—particularly as soluble oligomers—is strongly implicated in Alzheimer’s disease pathogenesis by disrupting synaptic signaling, impairing memory, and contributing to plaque formation.

References
[1] Chen GF, et al. Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235. [2] Gu L, et al. J Neurochem. 2013 Aug;126(3):305-11.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%